BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.00+0.00 (0.00%)
Close on Nov 20, 2026Market cap $3.21BP/E –Yield –
BGM free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$3.94M, down 1395.3% from the year before. The highest annual figure on record is $10.62M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$3.94M | -1395.3% |
| FY2024 | Sep 30, 2024 | $304.11K | +129.6% |
| FY2023 | Sep 30, 2023 | $132.45K | -98.8% |
| FY2022 | Sep 30, 2022 | $10.62M | – |
| FY2021 | Sep 30, 2021 | -$1.15M | -124.8% |
| FY2020 | Sep 30, 2020 | $4.63M | – |
| FY2019 | Sep 30, 2019 | -$1.20M | -136.0% |
| FY2018 | Sep 30, 2018 | $3.32M | – |
See a number that looks wrong?